Code Codelist Code Codelist Extensible (Yes/No) Codelist Name CDISC Submission Value CDISC Synonym(s) CDISC Definition NCI Preferred Term C188714 DDF Activity Attribute Terminology DDF Activity Attribute Terminology DDF Activity Attribute Terminology A terminology value set relevant to the attributes of the activity. CDISC DDF Activity Attribute Terminology C70960 C188714 DDF Activity Attribute Terminology Clinical Study Activity Description The textual representation of the study activity. Clinical Study Activity Description C188842 C188714 DDF Activity Attribute Terminology Clinical Study Activity Name The literal identifier (i.e., distinctive designation) of the clinical study activity. Clinical Study Activity Name C188844 C188714 DDF Activity Attribute Terminology Next Activity Identifier A system identifier assigned to a study activity that occurs immediately after the current study activity. Next Activity Identifier C188843 C188714 DDF Activity Attribute Terminology Previous Activity Identifier A system identifier assigned to a study activity that occurs immediately prior to the current study activity. Previous Activity Identifier C188720 DDF Analysis Population Attribute Terminology DDF Analysis Population Attribute Terminology DDF Analysis Population Attribute Terminology A terminology value set relevant to the attributes of the analysis population. CDISC DDF Analysis Population Attribute Terminology C188854 C188720 DDF Analysis Population Attribute Terminology Target Study Population for Analysis Description The textual representation of the study population for analysis. Target Study Population for Analysis Description C188699 DDF Clinical Study Attribute Terminology DDF Clinical Study Attribute Terminology DDF Clinical Study Attribute Terminology A terminology value set relevant to the attributes of the clinical study. CDISC DDF Clinical Study Attribute Terminology C49802 C188699 DDF Clinical Study Attribute Terminology Study Title Official Study Title; Study Title; Trial Title The sponsor-defined name of the clinical study. Trial Title C142175 C188699 DDF Clinical Study Attribute Terminology Study Type Classification Study Type; Study Type Classification The nature of the investigation for which study information is being collected. (After clinicaltrials.gov) Study Type C188816 C188699 DDF Clinical Study Attribute Terminology Study Version A plan at a particular point in time for a study. Study Version C48281 C188699 DDF Clinical Study Attribute Terminology Trial Phase Trial Phase; Trial Phase Classification A step in the clinical research and development of a therapy from initial clinical trials to post-approval studies. NOTE: Clinical trials are generally categorized into four (sometimes five) phases. A therapeutic intervention may be evaluated in two or more phases simultaneously in different trials, and some trials may overlap two different phases. [21 CFR section 312.21; After ICH Topic E8 NOTE FOR GUIDANCE ON GENERAL CONSIDERATIONS FOR CLINICAL TRIALS, CPMP/ICH/291/95 March 1998] Trial Phase C188722 DDF Code Attribute Terminology DDF Code Attribute Terminology DDF Code Attribute Terminology A terminology value set relevant to the attributes of the code. CDISC DDF Code Attribute Terminology C188859 C188722 DDF Code Attribute Terminology Code System Name The literal identifier (i.e., distinctive designation) of the system used to assign and/or manage codes. Code System Name C188868 C188722 DDF Code Attribute Terminology Code System Version The version of the code system. Coding System Version C188858 C188722 DDF Code Attribute Terminology Code Value The literal value of a code. Code Value C188861 C188722 DDF Code Attribute Terminology Decode Standardized or dictionary-derived human readable text associated with a code. Decode Text C188713 DDF Encounter Attribute Terminology DDF Encounter Attribute Terminology DDF Encounter Attribute Terminology A terminology value set relevant to the attributes of the encounter. CDISC DDF Encounter Attribute Terminology C188836 C188713 DDF Encounter Attribute Terminology Clinical Encounter Description The textual representation of the protocol-defined clinical encounter. Clinical Encounter Description C171010 C188713 DDF Encounter Attribute Terminology Clinical Encounter Name The literal identifier (i.e., distinctive designation) for a protocol-defined clinical encounter. Clinical Encounter Name C188839 C188713 DDF Encounter Attribute Terminology Clinical Encounter Type A characterization or classification of contact between subject/patient and healthcare practitioner/researcher, during which an assessment or activity is performed. Clinical Encounter Type C188841 C188713 DDF Encounter Attribute Terminology Contact Mode The means by which an interaction occurs between the subject/participant and person or entity (e.g., a device). Contact Mode C188840 C188713 DDF Encounter Attribute Terminology Environmental Setting The environment/setting where the event, intervention, or finding occurred. Environmental Setting C188838 C188713 DDF Encounter Attribute Terminology Next Encounter Identifier A system identifier assigned to a clinical encounter that occurs immediately after the current clinical encounter. Next Clinical Encounter Identifier C188837 C188713 DDF Encounter Attribute Terminology Previous Encounter Identifier A system identifier assigned to a clinical encounter that occurs immediately prior to the current clinical encounter. Previous Clinical Encounter Identifier C188708 DDF Endpoint Attribute Terminology DDF Endpoint Attribute Terminology DDF Endpoint Attribute Terminology A terminology value set relevant to the attributes of the endpoint. CDISC DDF Endpoint Attribute Terminology C188824 C188708 DDF Endpoint Attribute Terminology Study Endpoint Description The textual representation of the study endpoint. Study Endpoint Description C188826 C188708 DDF Endpoint Attribute Terminology Study Endpoint Level A characterization or classification of the study endpoint that determines its category of importance relative to other study endpoints. Study Endpoint Level C188825 C188708 DDF Endpoint Attribute Terminology Study Endpoint Purpose Description The textual representation of the study endpoint purpose. Study Endpoint Purpose Description C188698 DDF Entity Terminology DDF Entity Terminology DDF Entity Terminology A terminology value set relevant to the entities within the CDISC digital data flow (DDF) model. CDISC DDF Entities Terminology C142427 C188698 DDF Entity Terminology Clinical Encounter Contact between subject/patient and healthcare practitioner/researcher, during which an assessment or activity is performed. Contact may be physical or virtual. Clinical Encounter C188811 C188698 DDF Entity Terminology Clinical Study Data Data collected in the course of a clinical study. Clinical Study Data C15206 C188698 DDF Entity Terminology Clinical Study A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials (also called interventional studies) and observational studies. [ClinicalTrials.gov] See also clinical trial. (CDISC Glossary) Clinical Study C25162 C188698 DDF Entity Terminology Code A symbol or combination of symbols which is assigned to the members of a collection. Code C188813 C188698 DDF Entity Terminology Estimand A precise description of the treatment effect reflecting the clinical question posed by a given clinical trial objective. It summarises at a population level what the outcomes would be in the same patients under different treatment conditions being compared. (ICH E9 R1 Addendum) Estimand C188815 C188698 DDF Entity Terminology Intercurrent Event An event(s) occurring after treatment initiation that affects either the interpretation or the existence of the measurements associated with the clinical question of interest. (ICH E9 Addendum on Estimands) Intercurrent Event C25218 C188698 DDF Entity Terminology Intervention The drug, device, therapy, or process under investigation in a clinical study that is believed to have an effect on outcomes of interest in a study (e.g., health-related quality of life, efficacy, safety, pharmacoeconomics). [After https://grants.nih.gov/grants/policy/faq_clinical_trial_definition.htm#5224] Intervention or Procedure C19711 C188698 DDF Entity Terminology Organization A formalized group of persons or other organizations collected together for a common purpose (such as administrative, legal, political) and the infrastructure to carry out that purpose. (BRIDG) Professional Organization or Group C98769 C188698 DDF Entity Terminology Procedure Medical Procedure Any activity performed by manual and/or instrumental means for the purpose of diagnosis, assessment, therapy, prevention, or palliative care. Physical Medical Procedure C71473 C188698 DDF Entity Terminology Study Activity An action, undertaking, or event, which is anticipated to be performed or observed, or was performed or observed, according to the study protocol during the execution of the study. Study Activity C174447 C188698 DDF Entity Terminology Study Arm Arm A planned pathway assigned to the subject as they progress through the study, usually referred to by a name that reflects one or more treatments, exposures, and/or controls included in the path. Study Arm C188810 C188698 DDF Entity Terminology Study Design Cell A partitioning of a study arm into individual pieces, which are associated with an epoch and any number of sequential elements within that epoch. Study Design Cell C142735 C188698 DDF Entity Terminology Study Design Element A basic building block for time within a clinical study comprising the following characteristics: a description of what happens to the subject during the element; a definition of the start of the element; a rule for ending the element. Trial Design Element C15320 C188698 DDF Entity Terminology Study Design A plan detailing how a study will be performed in order to represent the phenomenon under examination, to answer the research questions that have been asked, and informing the statistical approach. Study Design C25212 C188698 DDF Entity Terminology Study Endpoint A defined variable intended to reflect an outcome of interest that is statistically analyzed to address a particular research question. NOTE: A precise definition of an endpoint typically specifies the type of assessments made, the timing of those assessments, the assessment tools used, and possibly other details, as applicable, such as how multiple assessments within an individual are to be combined. [After BEST Resource] (CDISC Glossary) End Point C71738 C188698 DDF Entity Terminology Study Epoch A named time period defined in the protocol, wherein a study activity is specified and unchanging throughout the interval, to support a study-specific purpose. Clinical Trial Epoch C83082 C188698 DDF Entity Terminology Study Identifier A sequence of characters used to identify, name, or characterize the study. Study Identifier C142450 C188698 DDF Entity Terminology Study Objective The reason for performing a study in terms of the scientific questions to be answered by the analysis of data collected during the study. Clinical Trial Objective C93490 C188698 DDF Entity Terminology Study Protocol Version A plan at a particular point in time for a formal investigation to assess the utility, impact, pharmacological, physiological, and/or psychological effects of a particular treatment, procedure, drug, device, biologic, food product, cosmetic, care plan, or subject characteristic. (BRIDG) Study Protocol Version C188814 C188698 DDF Entity Terminology Target Study Population for Analysis A target study population on which an analysis is performed. These may be represented by the entire study population, a subgroup defined by a particular characteristic measured at baseline, or a principal stratum defined by the occurrence (or non-occurrence, depending on context) of a specific intercurrent event. (ICH E9 R1 Addendum) Target Study Population for Analysis C142728 C188698 DDF Entity Terminology Target Study Population Target Population The population within the general population for which the study results can be generalized. Target Study Population C82567 C188698 DDF Entity Terminology Transition Rule A guide that governs the allocation of subjects to operational options at a discrete decision point or branch (e.g., assignment to a particular arm, discontinuation) within a clinical trial plan. Transition Rule C112038 C188698 DDF Entity Terminology Trial Disease/Condition Indication Description Trial Disease/Condition Indication; Trial Disease/Condition Indication Description The textual representation of the condition, disease or disorder that the clinical trial is intended to investigate or address. Trial Indication C188812 C188698 DDF Entity Terminology Workflow Item Description The textual representation of the workflow item. Workflow Item Description C42753 C188698 DDF Entity Terminology Workflow The operational aspect of a work procedure: how tasks are structured, who performs them, what their relative order is, how they are synchronized, how information flows to support the tasks and how tasks are being tracked. Workflow C188719 DDF Estimand Attribute Terminology DDF Estimand Attribute Terminology DDF Estimand Attribute Terminology A terminology value set relevant to the attributes of the estimand. CDISC DDF Estimand Attribute Terminology C188853 C188719 DDF Estimand Attribute Terminology Population-Level Summary A synopsis of the clinical endpoint of interest within the analysis target study population. Population-Level Summary C188705 DDF Indication Attribute Terminology DDF Indication Attribute Terminology DDF Indication Attribute Terminology A terminology value set relevant to the attributes of the disease indication. CDISC DDF Indication Attribute Terminology C188822 C188705 DDF Indication Attribute Terminology Disease Indication Code A short sequence of characters that represents the disease indication. Disease Indication Code C112038 C188705 DDF Indication Attribute Terminology Trial Disease/Condition Indication Description Trial Disease/Condition Indication; Trial Disease/Condition Indication Description The textual representation of the condition, disease or disorder that the clinical trial is intended to investigate or address. Trial Indication C188721 DDF Intercurrent Event Attribute Terminology DDF Intercurrent Event Attribute Terminology DDF Intercurrent Event Attribute Terminology A terminology value set relevant to the attributes of the intercurrent event. CDISC DDF Intercurrent Event Attribute Terminology C188856 C188721 DDF Intercurrent Event Attribute Terminology Intercurrent Event Description The textual representation of the intercurrent event. Intercurrent Event Description C188855 C188721 DDF Intercurrent Event Attribute Terminology Intercurrent Event Name The literal identifier (i.e., distinctive designation) of the intercurrent event. Intercurrent Event Name C188857 C188721 DDF Intercurrent Event Attribute Terminology Intercurrent Event Strategy A textual description of the planned strategy to manage and/or mitigate intercurrent events. Intercurrent Event Strategy C188704 DDF Investigational Interventions Attribute Terminology DDF Investigational Interventions Attribute Terminology DDF Investigational Interventions Attribute Terminology A terminology value set relevant to the attributes of the investigational interventions. CDISC DDF Investigational Interventions Attribute Terminology C177931 C188704 DDF Investigational Interventions Attribute Terminology Intervention Description The textual representation of the study intervention. Intervention Description C188821 C188704 DDF Investigational Interventions Attribute Terminology Investigational Intervention Code A short sequence of characters that represents the investigational intervention. Investigational Intervention Code C188707 DDF Objective Attribute Terminology DDF Objective Attribute Terminology DDF Objective Attribute Terminology A terminology value set relevant to the attributes of the objective. CDISC DDF Objective Attribute Terminology C94090 C188707 DDF Objective Attribute Terminology Study Objective Description The textual representation of the study objective. (BRIDG) Study Objective Description C188823 C188707 DDF Objective Attribute Terminology Study Objective Level A characterization or classification of the study endpoint that determines its category of importance relative to other study objectives. Study Objective Level C188702 DDF Organization Attribute Terminology DDF Organization Attribute Terminology DDF Organization Attribute Terminology A terminology value set relevant to the attributes of the organization. CDISC DDF Organization Attribute Terminology C188819 C188702 DDF Organization Attribute Terminology Identifier Provider Organization Name The name of the organization that provides the identifier for the entity. Identifier Provider Organization Name C93401 C188702 DDF Organization Attribute Terminology Organization Identifier A unique symbol that establishes identity of the organization. (BRIDG) Organization Identifier C93874 C188702 DDF Organization Attribute Terminology Organization Name A non-unique textual identifier for the organization. (BRIDG) Organization Name C188820 C188702 DDF Organization Attribute Terminology Organization Type A characterization or classification of the formalized group of persons or other organizations collected together for a common purpose (such as administrative, legal, political) and the infrastructure to carry out that purpose. Organization Type C188716 DDF Procedure Attribute Terminology DDF Procedure Attribute Terminology DDF Procedure Attribute Terminology A terminology value set relevant to the attributes of the procedure. CDISC DDF Procedure Attribute Terminology C154626 C188716 DDF Procedure Attribute Terminology Procedure Code A symbol or combination of symbols which is assigned to medical procedure. Procedure Code C188848 C188716 DDF Procedure Attribute Terminology Procedure Type A characterization or classification of the study procedure. Study Procedure Type C188709 DDF Study Arm Attribute Terminology DDF Study Arm Attribute Terminology DDF Study Arm Attribute Terminology A terminology value set relevant to the attributes of the study Arm. CDISC DDF Study Arm Attribute Terminology C188828 C188709 DDF Study Arm Attribute Terminology Study Arm Data Origin Description The textual representation of the study arm data origin. Study Arm Data Origin Description C188829 C188709 DDF Study Arm Attribute Terminology Study Arm Data Origin Type A characterization or classification of the study arm with respect to where the study arm data originates. Study Arm Data Origin Type C93728 C188709 DDF Study Arm Attribute Terminology Study Arm Description Arm Description The textual representation of the arm for the study. Arm Description C170984 C188709 DDF Study Arm Attribute Terminology Study Arm Name The literal identifier (i.e., distinctive designation) of the study arm. Planned Study Arm Name C188827 C188709 DDF Study Arm Attribute Terminology Study Arm Type Name The literal identifier (i.e., distinctive designation) of the study arm type. Study Arm Type Name C188715 DDF Study Data Attribute Terminology DDF Study Data Attribute Terminology DDF Study Data Attribute Terminology A terminology value set relevant to the attributes of the study data. CDISC DDF Study Data Attribute Terminology C188846 C188715 DDF Study Data Attribute Terminology Clinical Study Data Description The textual representation of the study data. Clinical Study Data Description C188845 C188715 DDF Study Data Attribute Terminology Clinical Study Data Name The literal identifier (i.e., distinctive designation) for the study data. Clinical Study Data Name C188847 C188715 DDF Study Data Attribute Terminology Electronic Case Report Form Link The uniform resource locator used to access the digital case report form. Electronic Case Report Form Uniform Resource Locator C188703 DDF Study Design Attribute Terminology DDF Study Design Attribute Terminology DDF Study Design Attribute Terminology A terminology value set relevant to the attributes of the study design. CDISC DDF Study Design Attribute Terminology C98746 C188703 DDF Study Design Attribute Terminology Intervention Model Type Intervention Model The general design of the strategy for assigning interventions to participants in a clinical study. (clinicaltrials.gov) Intervention Model C49652 C188703 DDF Study Design Attribute Terminology Trial Intent Type Trial Intent Type The planned purpose of the therapy, device, or agent under study in the clinical trial. Clinical Study by Intent C49660 C188703 DDF Study Design Attribute Terminology Trial Type Trial Scope; Trial Type The nature of the interventional study for which information is being collected. Trial Type C188706 DDF Study Design Population Attribute Terminology DDF Study Design Population Attribute Terminology DDF Study Design Population Attribute Terminology A terminology value set relevant to the attributes of the study design population. CDISC DDF Study Design Population Attribute Terminology C70834 C188706 DDF Study Design Population Attribute Terminology Target Study Population Description The textual representation of the study population. Study Population Description C188711 DDF Study Element Attribute Terminology DDF Study Element Attribute Terminology DDF Study Element Attribute Terminology A terminology value set relevant to the attributes of the study element. CDISC DDF Study Element Attribute Terminology C188834 C188711 DDF Study Element Attribute Terminology Study Design Element Description The textual representation of the study design element. Study Design Element Description C188833 C188711 DDF Study Element Attribute Terminology Study Design Element Name The literal identifier (i.e., distinctive designation) of the study design element. Study Design Element Name C188710 DDF Study Epoch Attribute Terminology DDF Study Epoch Attribute Terminology DDF Study Epoch Attribute Terminology A terminology value set relevant to the attributes of the study epoch. CDISC DDF Study Epoch Attribute Terminology C188832 C188710 DDF Study Epoch Attribute Terminology Next Epoch Identifier A system identifier assigned to the epoch that occurs immediately after the current epoch. Next Epoch Identifier C188831 C188710 DDF Study Epoch Attribute Terminology Previous Epoch Identifier A system identifier assigned to the epoch that occurs immediately prior to the current epoch. Previous Epoch Identifier C93824 C188710 DDF Study Epoch Attribute Terminology Study Epoch Description The textual representation of the study epoch. Epoch Description C93825 C188710 DDF Study Epoch Attribute Terminology Study Epoch Name The literal identifier (i.e., distinctive designation) of the study epoch, i.e., the named time period defined in the protocol, wherein a study activity is specified and unchanging throughout the interval, to support a study-specific purpose. Epoch Name C188830 C188710 DDF Study Epoch Attribute Terminology Study Epoch Type A characterization or classification of the study epoch, i.e., the named time period defined in the protocol, wherein a study activity is specified and unchanging throughout the interval, to support a study-specific purpose. Study Epoch Type C188701 DDF Study Identifier Attribute Terminology DDF Study Identifier Attribute Terminology DDF Study Identifier Attribute Terminology A terminology value set relevant to the attributes of the study identifier. CDISC DDF Study Identifier Attribute Terminology C83082 C188701 DDF Study Identifier Attribute Terminology Study Identifier A sequence of characters used to identify, name, or characterize the study. Study Identifier C188700 DDF Study Protocol Version Attribute Terminology DDF Study Protocol Version Attribute Terminology DDF Study Protocol Version Attribute Terminology A terminology value set relevant to the attributes of the study protocol version. CDISC DDF Study Protocol Version Attribute Terminology C132345 C188700 DDF Study Protocol Version Attribute Terminology Brief Protocol Title Abbreviated Protocol Title The short descriptive name for the protocol. Brief Protocol Title C132346 C188700 DDF Study Protocol Version Attribute Terminology Official Protocol Title The formal descriptive name for the protocol. Official Protocol Title C188818 C188700 DDF Study Protocol Version Attribute Terminology Protocol Status A condition of the protocol at a point in time with respect to its state of readiness for implementation. Study Protocol Status C94105 C188700 DDF Study Protocol Version Attribute Terminology Public Protocol Title The descriptive name of the protocol that is intended for the lay public, written in easily understood language. Study Protocol Document Version Public Title C132350 C188700 DDF Study Protocol Version Attribute Terminology Scientific Protocol Title A more extensive descriptive name of the protocol that is intended for medical professionals, written using medical and scientific language. Scientific Protocol Title C188817 C188700 DDF Study Protocol Version Attribute Terminology Study Protocol Amendment Effective Date The date and time specifying when the protocol amendment takes effect or becomes operative. Study Protocol Amendment Effective Date C132347 C188700 DDF Study Protocol Version Attribute Terminology Study Protocol Amendment A written description of a change(s) to, or formal clarification of, a protocol. (ICH E6) Protocol Amendment C93490 C188700 DDF Study Protocol Version Attribute Terminology Study Protocol Version A plan at a particular point in time for a formal investigation to assess the utility, impact, pharmacological, physiological, and/or psychological effects of a particular treatment, procedure, drug, device, biologic, food product, cosmetic, care plan, or subject characteristic. (BRIDG) Study Protocol Version C188712 DDF Transition Rule Attribute Terminology DDF Transition Rule Attribute Terminology DDF Transition Rule Attribute Terminology A terminology value set relevant to the attributes of the transition rule. CDISC DDF Transition Rule Attribute Terminology C188835 C188712 DDF Transition Rule Attribute Terminology Transition Rule Description The textual representation of the transition rule. Transition Rule Description C188717 DDF Workflow Attribute Terminology DDF Workflow Attribute Terminology DDF Workflow Attribute Terminology A terminology value set relevant to the attributes of the workflow. CDISC DDF Workflow Attribute Terminology C188849 C188717 DDF Workflow Attribute Terminology Workflow Description The textual representation of the workflow. Workflow Description C188718 DDF Workflow Item Attribute Terminology DDF Workflow Item Attribute Terminology DDF Workflow Item Attribute Terminology A terminology value set relevant to the attributes of the workflow item. CDISC DDF Workflow Item Attribute Terminology C188852 C188718 DDF Workflow Item Attribute Terminology Next Workflow Item Identifier A system identifier assigned to a workflow item that occurs immediately after the current workflow item. Next Workflow Item Identifier C188851 C188718 DDF Workflow Item Attribute Terminology Previous Workflow Item Identifier A system identifier assigned to a workflow item that occurs immediately prior to the current workflow item. Previous Workflow Item Identifier C188812 C188718 DDF Workflow Item Attribute Terminology Workflow Item Description The textual representation of the workflow item. Workflow Item Description C188728 Encounter Type Value Set Terminology Encounter Type Value Set Terminology Encounter Type Value Set Terminology The terminology relevant to the encounter type. CDISC DDF Encounter Type Value Set Terminology C25716 C188728 Encounter Type Value Set Terminology Visit The act of going to see some person or place or thing; it can cover a short or long period but refers to a non-permanent arrangement. Visit C188726 Endpoint Level Value Set Terminology Endpoint Level Value Set Terminology Endpoint Level Value Set Terminology The terminology relevant to the endpoint level. CDISC DDF Endpoint Level Value Set Terminology C170559 C188726 Endpoint Level Value Set Terminology Exploratory Endpoint Endpoint(s) that may include clinically important events that are expected to occur too infrequently to show a treatment effect or endpoints that for other reasons are thought to be less likely to show an effect but are included to explore new hypotheses. (After FDA-NIH Protocol Template) Exploratory Endpoint C94496 C188726 Endpoint Level Value Set Terminology Primary Endpoint Endpoint(s) of greatest importance that is the basis for concluding whether the study met its objective(s) and provides a clinically relevant, valid, and reliable measure of the primary objective(s). (After FDA-NIH Protocol Template) Primary Endpoint C139173 C188726 Endpoint Level Value Set Terminology Secondary Endpoint Endpoint(s) that may provide supportive information about the effect of the study intervention(s) on the primary endpoint or demonstrate additional effects on the disease or condition. (After FDA-NIH Protocol Template) Secondary Endpoint C127262 Yes Environmental Setting SETTING Environmental Setting Terminology relevant to the surroundings or environment. CDISC SDTM Environmental Setting Terminology C127785 C127262 Environmental Setting CHILD CARE CENTER An establishment that provides care for infants and children. Childcare Center C51282 C127262 Environmental Setting CLINIC A health care facility where subjects or patients may receive assessments, procedures, or treatments that are provided by physicians and other healthcare providers. Clinic C48953 C127262 Environmental Setting FARM A tract of land cultivated for the purpose of agricultural production or devoted to the raising and breeding of domestic animals. Farm C102650 C127262 Environmental Setting FIELD A setting outside the clinic or a comparable health care facility, e.g. a doctor's office, the subject's home or workplace, a school, a public park, or a restaurant. In the Field C21541 C127262 Environmental Setting HEALTH FACILITY The buildings and organizations where healthcare services are provided. Healthcare Facility C18002 C127262 Environmental Setting HOME A person's place of residence. Home C16696 C127262 Environmental Setting HOSPITAL An institution that provides medical, surgical, or psychiatric care and treatment for the sick or the injured. Hospital C102647 C127262 Environmental Setting HOUSEHOLD ENVIRONMENT The area in which an individual lives. Household Environment C41206 C127262 Environmental Setting INSTITUTION An established society, corporation, foundation or other organization founded and united for a specific purpose, e.g. for health-related research; also used to refer to a building or buildings occupied or used by such organization. Institution C181529 C127262 Environmental Setting MOTOR VEHICLE A motorized conveyance for people and goods. Motor Vehicle C102679 C127262 Environmental Setting NON-HOUSEHOLD ENVIRONMENT An area outside of that in which an individual lives. Non-household Environment C181530 C127262 Environmental Setting NOT IN CLINIC Any environmental setting outside of a clinic. Not In Clinic C16281 C127262 Environmental Setting OUTPATIENT CLINIC A medical care center that provides healthcare services on an outpatient basis. Ambulatory Care Facility C85862 C127262 Environmental Setting PRISON An institution where persons are confined for punishment and to protect the public. Correctional Institution C17118 C127262 Environmental Setting SCHOOL An educational institution. School C85863 C127262 Environmental Setting SHELTER Temporary housing for displaced or at-risk persons. Shelter C102712 C127262 Environmental Setting SOCIAL SETTING The surroundings or environment in which social activities occur. Social Setting C17556 C127262 Environmental Setting WORKSITE Place or physical location of work or employment. Worksite C99079 Yes Epoch EPOCH Epoch The name of the EPOCH. CDISC SDTM Epoch Terminology C125938 C99079 Epoch BASELINE A period in a clinical study after eligibility has been met and before the start of treatment, at which baseline measurements are collected. Baseline Epoch C102255 C99079 Epoch BLINDED TREATMENT A period in a clinical study during which subjects receive blinded therapeutic treatment. Blinded Treatment Epoch C123452 C99079 Epoch CONTINUATION TREATMENT Continuation Phase A period in a clinical study during which subjects receive continuation treatment. Continuation Therapy Epoch C99158 C99079 Epoch FOLLOW-UP A period in a clinical study during which information about the health status of an individual is obtained after study interventions have concluded. Clinical Study Follow-up C123453 C99079 Epoch INDUCTION TREATMENT Induction Phase; Intensive Phase A period in a clinical study during which subjects receive induction treatment. Induction Therapy Epoch C16032 C99079 Epoch LONG-TERM FOLLOW-UP A period in a clinical study during which information about the health status of an individual is obtained long after study interventions have concluded. Long-term Follow-up C165873 C99079 Epoch OBSERVATION A period in a clinical study during which subjects are observed, without any planned intervention. Observation Study Epoch C102256 C99079 Epoch OPEN LABEL TREATMENT A period in a clinical study during which subjects receive open label therapeutic treatment. Open Label Treatment Epoch C98779 C99079 Epoch RUN-IN A period in a clinical study that occurs before the commencement of the primary clinical study investigation, during which subjects may be assessed for suitability in the clinical study, withdrawn from existing therapy, trained in study methodology or evaluated for any other protocol-specified reason. Run-in Period C48262 C99079 Epoch SCREENING A period in a clinical study during which subjects are evaluated for participation in the study. Trial Screening C101526 C99079 Epoch TREATMENT A period in a study during which subjects are receiving investigational therapy or treatment. Treatment Epoch C42872 C99079 Epoch WASHOUT A period of time during a study when a subject is taken off of the investigational therapy or treatment in order to reduce the amount of investigational product within the body. Washout Period C99076 Yes Intervention Model Response INTMODEL Intervention Model Response A terminology codelist relevant to the trial design developed to compare treatment groups. CDISC SDTM Intervention Model Terminology C82637 C99076 Intervention Model Response CROSS-OVER Participants receive one of two or more alternative intervention(s) during the initial epoch of the study and receive other intervention(s) during the subsequent epoch(s) of the study. Crossover Study C82638 C99076 Intervention Model Response FACTORIAL Two or more interventions, each alone or in combination, are evaluated in parallel against a control group. This study design allows for the comparison of active drug to placebo, presence of drug-drug interactions, and comparison of active drugs against each other. Factorial Study C82639 C99076 Intervention Model Response PARALLEL Participants are assigned to one of two or more treatment groups in parallel for the duration of the study. Parallel Study C142568 C99076 Intervention Model Response SEQUENTIAL Groups of participants are assigned to receive interventions based on prior milestones being reached in the study. (clinicaltrials.gov) Group Sequential Design C82640 C99076 Intervention Model Response SINGLE GROUP All trial participants are assigned to a single treatment group for the duration of the study. Single Group Study C171445 Yes Mode of Subject Contact CNTMODE Mode of Subject Contact Terminology relevant to the means by which interaction occurs between the subject and person or entity. CDISC SDTM Mode of Subject Contact Terminology C175574 C171445 Mode of Subject Contact IN PERSON In-Person An interaction that takes place in the physical presence of someone else. In Person C177933 C171445 Mode of Subject Contact IVRS Interactive Voice Response System A type of automated system in which individuals can access information menus containing pre-recorded or dynamically generated information with voice prompts, without the need for an agent or operator. Interactive Voice Response System C171525 C171445 Mode of Subject Contact REMOTE AUDIO VIDEO A form of remote communication by audio video technology. Audio-Videoconferencing C171524 C171445 Mode of Subject Contact REMOTE AUDIO A form of remote communication by audio technology. Audioconferencing C171533 C171445 Mode of Subject Contact SHIPMENT CONFIRMED BY SIGNATURE Receipt of shipped material was confirmed by signature. Shipment Confirmed by Signature C171537 C171445 Mode of Subject Contact TELEPHONE CALL Communication by way of telephone. Telephone Call C188725 Objective Level Value Set Terminology Objective Level Value Set Terminology Objective Level Value Set Terminology The terminology relevant to the objective level. CDISC DDF Objective Level Value Set Terminology C85826 C188725 Objective Level Value Set Terminology Study Primary Objective Study Primary Objective; Trial Primary Objective A principle objective of the study. Trial Primary Objective C85827 C188725 Objective Level Value Set Terminology Study Secondary Objective Study Secondary Objective; Trial Secondary Objective An auxiliary objective of the study. Trial Secondary Objective C188724 Organization Type Value Set Terminology Organization Type Value Set Terminology Organization Type Value Set Terminology The terminology relevant to the organization type. CDISC DDF Organization Type Value Set Terminology C93453 C188724 Organization Type Value Set Terminology Clinical Study Registry An organization (typically a government agency) that administers the registration of studies. (BRIDG) Study Registry C70793 C188724 Organization Type Value Set Terminology Clinical Study Sponsor Clinical Study Sponsor; Sponsor; Study Sponsor An individual, company, institution, or organization that takes responsibility for the initiation, management, and/or financing of a clinical study. [After ICH E6, WHO, 21 CFR 50.3 (e), and after IDMP] Clinical Study Sponsor C188863 C188724 Organization Type Value Set Terminology Regulatory Agency Regulator; Regulatory Body An organization (typically a government agency) that is responsible for implementing and enforcing laws, licensing and regulating products and services, promoting the use of standards, and ensuring safety and consumer protections. Regulatory Agency C188723 Protocol Status Value Set Terminology Protocol Status Value Set Terminology Protocol Status Value Set Terminology The terminology relevant to the protocol status. CDISC DDF Protocol Status Value Set Terminology C25425 C188723 Protocol Status Value Set Terminology Approved Acceptance as satisfactory by an authoritative body; established by authority; given authoritative approval. Approval C85255 C188723 Protocol Status Value Set Terminology Draft A preliminary version of a written work, design, or picture. Draft C25508 C188723 Protocol Status Value Set Terminology Final Conclusive in a process or progression. Final C63553 C188723 Protocol Status Value Set Terminology Obsolete No longer in use or valid; old. Obsolete C188862 C188723 Protocol Status Value Set Terminology Pending Review Draft Pending Review A preliminary version of a written work, design, or picture that is awaiting review. Pending Review C188727 Study Arm Data Origin Type Value Set Terminology Study Arm Data Origin Type Value Set Terminology Study Arm Data Origin Type Value Set Terminology The terminology relevant to the study arm data origin type. CDISC DDF Study Arm Data Origin Type Value Set Terminology C188866 C188727 Study Arm Data Origin Type Value Set Terminology Data Generated Within Study Data that are generated from the current study. Data Generated Within Study C188864 C188727 Study Arm Data Origin Type Value Set Terminology Historical Data Data from studies that have occurred in the past. Historical Data C165830 C188727 Study Arm Data Origin Type Value Set Terminology Real World Data Data relating to patient health status and/or the delivery of health care routinely collected from sources other than traditional clinical trials. NOTE: Examples of sources include data derived from electronic health records (EHRs); medical claims and billing data; data from product and disease registries; patient-generated data, including from in-home-use settings; and data gathered from other sources that can inform on health status, such as mobile devices. [After 21 U.S.C. 355g(b)).5 and Framework for FDA's Real-World Evidence Program December 2018] See also Real-World Evidence (RWE) Real-world Data C176263 C188727 Study Arm Data Origin Type Value Set Terminology Synthetic Data Data that are artificially created rather than being generated by actual events. NOTE: Data are often created with the help of algorithms and used for a wide range of activities, including as test data for new products and tools, for model validation, and in AI optimization. [After The Ultimate Guide to Synthetic Data in 2020, August 29, 2020]. See also artificial intelligence. Synthetic Data C188865 C188727 Study Arm Data Origin Type Value Set Terminology Virtual Data Data that are generated from virtual encounters between investigators and subjects. Virtual Data C99077 No Study Type Response STYPE Study Type Response A terminology codelist relevant to the role the study plays in determining the interventions a subject receives. CDISC SDTM Study Type Terminology C98722 C99077 Study Type Response EXPANDED ACCESS Compassionate Use Studies that provide a means for obtaining an experimental drug or device for patients who are not adequately treated by existing therapy, who do not meet the eligibility criteria for enrollment, or who are otherwise unable to participate in another clinical study. Expanded Access Study C98388 C99077 Study Type Response INTERVENTIONAL Studies in which individuals are assigned by an investigator based on a protocol to receive specific interventions. Subjects may receive diagnostic, therapeutic or other types of interventions. The assignment of the intervention may or may not be random. The individuals are then followed and biomedical and/or health outcomes are assessed. Interventional Study C16084 C99077 Study Type Response OBSERVATIONAL Studies in which biomedical and/or health outcomes are assessed in pre-defined groups of individuals. Subjects in the study may receive diagnostic, therapeutic, or other interventions, but the investigator does not assign specific interventions to the subjects of the study. Observational Study C129000 C99077 Study Type Response PATIENT REGISTRY Observational studies which include an organized system that uses observational methods to collect uniform data (clinical and other) prospectively for a population defined by a particular disorder/disease, condition (including susceptibility to a disorder), or exposure (including products, health care services, and/or procedures) and that serves a predetermined scientific, clinical, or policy purpose. Patient registries may be single purpose or on-going data collection programs that address one or more questions. (AHRQ) Patient Registry Study C66736 Yes Trial Intent Type Response TINDTP Trial Intent Type Response A terminology codelist relevant to the responses for the planned purpose of the therapy, device, or agent under study in the clinical trial. CDISC SDTM Trial Indication Type Terminology C15714 C66736 Trial Intent Type Response BASIC SCIENCE Basic Research A type of study designed to examine the basic mechanism of action (e.g., physiology, biomechanics) of an intervention. (ClinicalTrials.gov) Basic Research C49654 C66736 Trial Intent Type Response CURE A type of study designed to evaluate intervention(s) aimed to cure a disease or condition. Cure Study C139174 C66736 Trial Intent Type Response DEVICE FEASIBILITY An intervention of a device product is being evaluated to determine the feasibility of the product or to test a prototype device and not health outcomes. Such studies are conducted to confirm the design and operating specifications of a device before beginning a full clinical trial. (ClinicalTrials.gov) Device Feasibility Study C49653 C66736 Trial Intent Type Response DIAGNOSIS A type of study designed to evaluate intervention(s) aimed at identifying a disease or condition. Diagnosis Study C170629 C66736 Trial Intent Type Response DISEASE MODIFYING A type of study designed to evaluate the effects of treatment(s) intended to cause a change in disease, syndrome, or condition beyond the point of treatment administration. Disease Modifying Treatment Study C15245 C66736 Trial Intent Type Response HEALTH SERVICES RESEARCH A type of study designed to evaluate the delivery, processes, management, organization or financing of health care. (ClinicalTrials.gov) Health Services Research C49655 C66736 Trial Intent Type Response MITIGATION A type of study designed to identify actions necessary to eliminate or reduce the risk to human life or well-being as a result of a particular medication or treatment regimen. (NCI) Adverse Effect Mitigation Study C49657 C66736 Trial Intent Type Response PREVENTION Prophylaxis Study A type of study designed to identify actions necessary to permanently eliminate or reduce the long-term risk to human life as a result of a particular medication or treatment regimen. Prevention Study C71485 C66736 Trial Intent Type Response SCREENING A type of study designed to assess or examine methods of identifying a condition (or risk factors for a condition) in people who are not yet known to have the condition (or risk factor). (Clinicaltrials.gov) Screening Study C71486 C66736 Trial Intent Type Response SUPPORTIVE CARE A type of study designed to evaluate one or more interventions where the primary intent is to maximize comfort, minimize side effects or mitigate against a decline in the subject's health or function. In general, supportive care interventions are not intended to cure a disease. (ClinicalTrials.gov) Supportive Care Study C49656 C66736 Trial Intent Type Response TREATMENT Therapy Trial A type of study designed to evaluate intervention(s) for treatment of disease, syndrome or condition. Treatment Study C66737 Yes Trial Phase Response TPHASE Trial Phase Response A terminology codelist relevant to the phase, or stage, of the clinical trial. CDISC SDTM Trial Phase Terminology C48660 C66737 Trial Phase Response NOT APPLICABLE NA; Not Applicable Determination of a value is not relevant in the current context. (NCI) Not Applicable C54721 C66737 Trial Phase Response PHASE 0 TRIAL 0; Pre-clinical Trial; Trial Phase 0 First-in-human trials, in a small number of subjects, that are conducted before Phase 1 trials and are intended to assess new candidate therapeutic and imaging agents. The study agent is administered at a low dose for a limited time, and there is no therapeutic or diagnostic intent. NOTE: FDA Guidance for Industry, Investigators, and Reviewers: Exploratory IND Studies, January 2006 classifies such studies as Phase 1. NOTE: A Phase 0 study might not include any drug delivery but may be an exploration of human material from a study (e.g., tissue samples or biomarker determinations). [Improving the Quality of Cancer Clinical Trials: Workshop summary-Proceedings of the National Cancer Policy Forum Workshop, improving the Quality of Cancer Clinical Trials (Washington, DC, Oct 2007)] (CDISC glossary) Phase 0 Trial C15600 C66737 Trial Phase Response PHASE I TRIAL 1; Trial Phase 1 The initial introduction of an investigational new drug into humans. Phase 1 studies are typically closely monitored and may be conducted in patients or normal volunteer subjects. NOTE: These studies are designed to determine the metabolism and pharmacologic actions of the drug in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness. During Phase 1, sufficient information about the drug's pharmacokinetics and pharmacological effects should be obtained to permit the design of well-controlled, scientifically valid, Phase 2 studies. The total number of subjects and patients included in Phase I studies varies with the drug, but is generally in the range of 20 to 80. Phase 1 studies also include studies of drug metabolism, structure-activity relationships, and mechanism of action in humans, as well as studies in which investigational drugs are used as research tools to explore biological phenomena or disease processes. [After FDA CDER Handbook, ICH E8] (CDISC glossary) Phase I Trial C15693 C66737 Trial Phase Response PHASE I/II TRIAL 1-2; Trial Phase 1-2 A class of clinical study that combines elements characteristic of traditional Phase I and Phase II trials. See also Phase I, Phase II. Phase I/II Trial C15601 C66737 Trial Phase Response PHASE II TRIAL 2; Trial Phase 2 Phase 2. Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associated with the drug. NOTE: Phase 2 studies are typically well controlled, closely monitored, and conducted in a relatively small number of patients, usually involving no more than several hundred subjects. [After FDA CDER Handbook, ICH E8] (CDISC glossary) Phase II Trial C15694 C66737 Trial Phase Response PHASE II/III TRIAL 2-3; Trial Phase 2-3 A class of clinical study that combines elements characteristic of traditional Phase II and Phase III trials. Phase II/III Trial C49686 C66737 Trial Phase Response PHASE IIA TRIAL 2A; Trial Phase 2A A clinical research protocol generally referred to as a pilot or feasibility trial that aims to prove the concept of the new intervention in question. (NCI) Phase IIa Trial C49688 C66737 Trial Phase Response PHASE IIB TRIAL 2B; Trial Phase 2B A clinical research protocol generally referred to as a well-controlled and pivotal trial that aims to prove the mechanism of action of the new intervention in question. A pivotal study will generally be well-controlled, randomized, of adequate size, and whenever possible, double-blind. (NCI) Phase IIb Trial C15602 C66737 Trial Phase Response PHASE III TRIAL 3; Trial Phase 3 Phase 3. Studies are expanded controlled and uncontrolled trials. They are performed after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather the additional information about effectiveness and safety that is needed to confirm efficacy and evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling. NOTE: Phase 3 studies usually include from several hundred to several thousand subjects. [After FDA CDER Handbook, ICH E8] (CDISC glossary) Phase III Trial C49687 C66737 Trial Phase Response PHASE IIIA TRIAL 3A; Trial Phase 3A A classification typically assigned retrospectively to a Phase III trial upon determination by regulatory authorities of a need for a Phase III B trial. (NCI) Phase IIIa Trial C49689 C66737 Trial Phase Response PHASE IIIB TRIAL 3B; Trial Phase 3B A subcategory of Phase III trials done near the time of approval to elicit additional findings. NOTE: Dossier review may continue while associated Phase IIIB trials are conducted. These trials may be required as a condition of regulatory authority approval. Phase IIIb Trial C15603 C66737 Trial Phase Response PHASE IV TRIAL 4; Trial Phase 4 Phase 4. Postmarketing (Phase 4) studies to delineate additional information about the drug's risks, benefits, and optimal use that may be requested by regulatory authorities in conjunction with marketing approval. NOTE: These studies could include, but would not be limited to, studying different doses or schedules of administration than were used in Phase 2 studies, use of the drug in other patient populations or other stages of the disease, or use of the drug over a longer period of time. [After FDA CDER Handbook, ICH E8] (CDISC glossary) Phase IV Trial C47865 C66737 Trial Phase Response PHASE V TRIAL 5; Trial Phase 5 Postmarketing surveillance is sometimes referred to as Phase V. Phase V Trial C66739 Yes Trial Type Response TTYPE Trial Type Response A terminology codelist relevant to the type of primary outcome or endpoint that the protocol is designed to evaluate. CDISC SDTM Trial Type Terminology C158283 C66739 Trial Type Response ADHESION PERFORMANCE A type of study designed to evaluate the strength of the bond between an adhesive and the application surface. Adhesion Performance Study C158284 C66739 Trial Type Response ALCOHOL EFFECT A type of study designed to evaluate the effects of alcohol on investigational product safety and/or efficacy. Alcohol Effect Study C49664 C66739 Trial Type Response BIO-AVAILABILITY A study of the degree to which or rate at which a drug or other substance is absorbed or becomes available at the site of physiological activity after administration. (NCI) Bioavailability Study C49665 C66739 Trial Type Response BIO-EQUIVALENCE A study most often used to compare the efficacy of different formulations to treat a given disease. It is the testing of an old versus a new formulation in healthy volunteers or subjects with the disease under study and usually in one dose. (NCI) Therapeutic Equivalency Study C158288 C66739 Trial Type Response BIOSIMILARITY A type of study designed to evaluate whether a biologic test article is highly similar in function and effect to an existing biologic that has already been clinically tested and approved for use. Biosimilarity Study C158285 C66739 Trial Type Response DEVICE-DRUG INTERACTION A type of study designed to evaluate the interaction between a device and a drug, where the use of one may affect the disposition, function, efficacy, or safety of the other. Device-Drug Interaction Study C49653 C66739 Trial Type Response DIAGNOSIS A type of study designed to evaluate intervention(s) aimed at identifying a disease or condition. Diagnosis Study C158289 C66739 Trial Type Response DOSE FINDING An early phase clinical study with the objective of determining the optimal dose of an investigational product. Dose Finding Study C158290 C66739 Trial Type Response DOSE PROPORTIONALITY A type of study designed to evaluate the relationship between dose and resulting exposure. Dose Proportionality Study C127803 C66739 Trial Type Response DOSE RESPONSE A study of the effect of dose changes on the efficacy of a drug in order to determine the dose-response relationship and optimal dose of a therapy. Dose Response Study C158286 C66739 Trial Type Response DRUG-DRUG INTERACTION A type of study designed to evaluate the interaction between drugs, where the use of one may affect the disposition, efficacy, or safety of the other. Drug-Drug Interaction Study C178057 C66739 Trial Type Response ECG Electrocardiographic Study A study that evaluates the effect of a treatment on cardiac electrical activity, as assessed by electrocardiography. Electrocardiographic Study C49666 C66739 Trial Type Response EFFICACY A study of the relative therapeutic efficacy of treatment of a disease. Usually this is a Phase II or III study. (NCI) Efficacy Study C98729 C66739 Trial Type Response FOOD EFFECT Studies that are conducted to assess the effect of food on the rate and extent of absorption of a drug, either compared to a fasted state or to a reference drug. Food Effect Study C120842 C66739 Trial Type Response IMMUNOGENICITY A study that assesses an agent's ability to provoke an immune response. Immunogenicity Study C49662 C66739 Trial Type Response PHARMACODYNAMIC A study of the biochemical and physiological effect of a drug and the mechanism of drug action and the relationship between drug concentration and effect. (NCI) Pharmacodynamic Study C39493 C66739 Trial Type Response PHARMACOECONOMIC A study that assesses the value associated with a given drug in therapeutic and economic terms. This type of study is multidisciplinary in nature and takes into consideration the social and economic costs (resource utilization costs including direct, indirect, and intangible costs) of drug therapy in addition to its direct therapeutic benefits. Analyses relate the difference in therapeutic benefits to the difference in costs between treatment alternatives. (NCI) Pharmacoeconomic Study C129001 C66739 Trial Type Response PHARMACOGENETIC A study that assesses variation in DNA sequence, usually within a single gene, and its effect on drug response. Pharmacogenetic Study C49661 C66739 Trial Type Response PHARMACOGENOMIC A study that identifies or assesses variations within the entire genome, including DNA, RNA, or transcriptional elements, and its effects on drug response. Pharmacogenomic Study C49663 C66739 Trial Type Response PHARMACOKINETIC A study of the process by which a drug is absorbed, distributed, metabolized, and eliminated by the body. (NCI) Pharmacokinetic Study C161477 C66739 Trial Type Response POSITION EFFECT A type of study designed to evaluate the effect of body position during and/or after administration of the investigational product. Position Effect Trial C49657 C66739 Trial Type Response PREVENTION Prophylaxis Study A type of study designed to identify actions necessary to permanently eliminate or reduce the long-term risk to human life as a result of a particular medication or treatment regimen. Prevention Study C174366 C66739 Trial Type Response REACTOGENICITY A type of study designed to evaluate the expected, acute types of immunological responses, sometimes considered excessive, following agent administration. Reactogenicity Study C49667 C66739 Trial Type Response SAFETY A study that assesses the medical risks to a subject. Safety is usually assessed by examining a wide range of clinical parameters, including adverse events, vital signs, physical exam, laboratory tests. Safety Study C161478 C66739 Trial Type Response SWALLOWING FUNCTION A type of study designed to evaluate the effect of the investigational product on the physiologic act of swallowing. Swallowing Function Trial C158287 C66739 Trial Type Response THOROUGH QT TQT Study A type of study designed to evaluate the ability of an investigational product and/or approved drug to delay cardiac ventricular repolarization as detected by QT prolongation and other ECG parameters. Thorough QT Study C98791 C66739 Trial Type Response TOLERABILITY A type of safety study that assesses the degree to which overt adverse effects can be tolerated by the subject. Tolerability Study C49656 C66739 Trial Type Response TREATMENT Therapy Trial A type of study designed to evaluate intervention(s) for treatment of disease, syndrome or condition. Treatment Study C161479 C66739 Trial Type Response USABILITY TESTING A type of study designed to evaluate the user experience with a product. Usability Testing Study C161480 C66739 Trial Type Response WATER EFFECT A type of study designed to evaluate the effects of water on investigational product safety and/or efficacy. Water Effect Trial